SREBF1 and colorectal carcinoma: Strikingly, both metastatic CRC cells, KM12SM and KM12L4a, showed reduced expression levels of SREBF1 (master transcription factor involved in de novo synthesis of fatty acids) and its downstream molecular targets FASN and SCD compared to control cells (Figure 6C).